Actinium Pharmaceuticals Inc (ATNM)
6.90
-0.27
(-3.77%)
USD |
NYAM |
Apr 23, 16:00
6.90
0.00 (0.00%)
After-Hours: 20:00
Actinium Pharmaceuticals Total Assets (Quarterly): 81.44M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 81.44M |
| September 30, 2023 | 88.94M |
| June 30, 2023 | 99.05M |
| March 31, 2023 | 102.03M |
| December 31, 2022 | 114.19M |
| September 30, 2022 | 116.82M |
| June 30, 2022 | 121.80M |
| March 31, 2022 | 74.56M |
| December 31, 2021 | 80.39M |
| September 30, 2021 | 84.48M |
| June 30, 2021 | 84.45M |
| March 31, 2021 | 75.10M |
| December 31, 2020 | 66.40M |
| September 30, 2020 | 50.53M |
| June 30, 2020 | 55.96M |
| March 31, 2020 | 8.364M |
| December 31, 2019 | 11.67M |
| September 30, 2019 | 16.32M |
| June 30, 2019 | 21.82M |
| March 31, 2019 | 12.24M |
| December 31, 2018 | 14.89M |
| September 30, 2018 | 15.70M |
| June 30, 2018 | 22.58M |
| March 31, 2018 | 28.14M |
| December 31, 2017 | 18.34M |
| Date | Value |
|---|---|
| September 30, 2017 | 21.72M |
| June 30, 2017 | 12.98M |
| March 31, 2017 | 18.24M |
| December 31, 2016 | 22.53M |
| September 30, 2016 | 17.26M |
| June 30, 2016 | 21.57M |
| March 31, 2016 | 23.34M |
| December 31, 2015 | 26.59M |
| September 30, 2015 | 25.05M |
| June 30, 2015 | 26.33M |
| March 31, 2015 | 20.06M |
| December 31, 2014 | 7.569M |
| September 30, 2014 | 12.60M |
| June 30, 2014 | 15.45M |
| March 31, 2014 | 6.560M |
| December 31, 2013 | 5.766M |
| September 30, 2013 | 4.05M |
| June 30, 2013 | 5.735M |
| March 31, 2013 | 3.357M |
| December 31, 2012 | 5.789M |
| September 30, 2012 | 0.00 |
| June 30, 2012 | 0.0001M |
| March 31, 2012 | 0.0001M |
| December 31, 2011 | 6.200M |
| September 30, 2011 | 0.0001M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
8.364M
Minimum
Mar 2020
121.80M
Maximum
Jun 2022
71.28M
Average
80.39M
Median
Dec 2021
Total Assets (Quarterly) Benchmarks
| Perspective Therapeutics Inc | 97.89M |
| Eli Lilly and Co | 64.01B |
| Cellectar Biosciences Inc | 12.08M |
| Bristol-Myers Squibb Co | 95.16B |
| Oragenics Inc | 4.966M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 45.07M |
| Shareholders Equity (Quarterly) | 36.38M |
| Current Ratio | 9.214 |